Clinical Orthopaedics and Related Research ®

A Publication of The Association of Bone and Joint Surgeons ®

Symposium: Papers Presented at the 2011 ISOLS Meeting in Beijing, China 11 articles

Articles

Compress® Knee Arthroplasty Has 80% 10-year Survivorship and Novel Forms of Bone Failure

John H. Healey MD, Carol D. Morris MD, Edward A. Athanasian MD, Patrick J. Boland MD

Compliant, self-adjusting compression technology is a novel approach for durable prosthetic fixation of the knee. However, the long-term survival of these constructs is unknown.

Constrained Total Hip Megaprosthesis for Primary Periacetabular Tumors

Takafumi Ueda MD, PhD, Shigeki Kakunaga MD, PhD, Satoshi Takenaka MD, PhD, Nobuhito Araki MD, PhD, Hideki Yoshikawa MD, PhD

Limb-salvage reconstruction for periacetabular malignant tumors is one of the most challenging problems in orthopaedic oncology. Reconstructive options include resection arthroplasty, endoprosthesis, allograft, recycled autobone graft, arthrodesis, and pseudarthrosis. However, no standard procedure exists because of rarity and clinical variability of the disease. We previously developed a megaprosthetic system with a constrained total hip mechanism (C-THA).

Can a Less Radical Surgery Using Photodynamic Therapy With Acridine Orange Be Equal to a Wide-margin Resection?

Takao Matsubara MD, Katsuyuki Kusuzaki MD, Akihiko Matsumine MD, Tomoki Nakamura MD, Akihiro Sudo MD

Wide-margin resections are an accepted method for treating soft tissue sarcoma. However, a wide-margin resection sometimes impairs function because of the lack of normal tissue. To preserve the normal tissue surrounding a tumor, we developed a less radical (ie, without a wide margin) surgical procedure using adjunctive photodynamic therapy and acridine orange for treating soft tissue sarcoma. However, whether this less radical surgical approach increases or decreases survival or whether it increases the risk of local recurrence remains uncertain.

Surgical Resection of Relapse May Improve Postrelapse Survival of Patients With Localized Osteosarcoma

Kwok Chuen Wong FHKAM (Orth), Vincent Lee FHKAM (Paed), MRCP, Matthew M. K. Shing FHKAM (Paed), MRCPCH, Shekhar Kumta PhD

Despite neoadjuvant chemotherapy and wide surgical ablation, 15% to 25% of patients with primary osteosarcoma will relapse (local recurrence or metastases). Neither chemotherapy nor radiation therapy alone will render a patient disease-free without concomitant surgical ablation of relapse. We prefer excision of relapse when possible. However, it is unclear whether excision enhances survival.

Making a Case for the Socioeconomic Determinacy of Survival in Osteosarcoma

Saminathan S. Nathan FRCS, John H. Healey FACS

The literature on osteosarcoma survival generally focuses on tumor and treatment variables, although it is unclear whether and how ethnic and socioeconomic factors might influence survival.

Which Implant Is Best After Failed Treatment for Pathologic Femur Fractures?

Jonathan Agner Forsberg MD, Rikard Wedin MD, PhD, Henrik Bauer MD, PhD

Successful treatment of pathologic femur fractures can preserve a patient’s independence and quality of life. The choice of implant depends on several disease- and patient-specific variables; however, its durability must generally match the patient’s estimated life expectancy. Failures do occur, however, it is unclear which implants are associated with greater risk of failure.

Computer-assisted Tumor Surgery in Malignant Bone Tumors

Kwok Chuen Wong MD, Shekhar Madhukar Kumta MD

Small recent case series using CT-based navigation suggest such approaches may aid in surgical planning and improve accuracy of intended resections, but the accuracy and clinical use have not been confirmed.

Surgical Technique: Tibia Cortical Strut Autograft Interposition Arthrodesis After Distal Radius Resection

Michiel A. J. Sande MD, PhD, Niels H. W. Geldorp MSc, P. D. Sander Dijkstra MD, PhD, Antonie H. M. Taminiau MD, PhD

Distal radius reconstruction after en bloc tumor resection remains a surgical challenge. Although several surgical techniques, either reconstructing the wrist or achieving a stable arthrodesis, have been described, it is unclear to what degree these restore function.

Giant Cell Tumor With Pathologic Fracture: Should We Curette or Resect?

Lizz Heijden MSc, P. D. Sander Dijkstra MD, PhD, Domenico A. Campanacci MD, PhD, C. L. Max H. Gibbons MD, PhD, Michiel A. J. Sande MD, PhD

Approximately one in five patients with giant cell tumor of bone presents with a pathologic fracture. However, recurrence rates after resection or curettage differ substantially in the literature and it is unclear when curettage is reasonable after fracture.

Joint-preserving Tumor Resection and Reconstruction Using Image-guided Computer Navigation

Kwok Chuen Wong MD, Shekhar Madhukar Kumta MD

Joint-preserving surgery is performed in select patients with bone sarcomas of extremities and allows patients to retain the native joint with better joint function. However, recurrences may relate to achieving adequate margins and there is frequently little room for error in tumors close to the joint surface. Further, the tumor margin on preoperative CT and/or MR images is difficult to transpose to the actual extent of tumor in the bone in the operating room.